Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice-Reference-Cited by-同舟云学术

Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice

Published:2022-06-22 Issue:2 Volume:481 Page:191-200
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Queipo Francisco Javier,Unamunzaga Gorka Muñiz,Negro Begoña Fuertes,Fuertes Sandra Gracia,Cortés Marina Álvarez,Tejedor Elena Carceller,Mañas Carmen María Bernal,Ariño Arceli Bono,Sjödahl Gottfrid,Beorlegui Carmen

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00428-022-03361-0.pdf

Reference45 articles.

1. Horwich A, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M et al (2019) EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. Ann Oncol 30(11):1697–1727

2. Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, Hernández V, Linares Espinós E, Lorch A, Neuzillet Y, Rouanne M, Thalmann GN, Veskimäe E, Ribal MJ, van der Heijden AG (2021) European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol 79(1):82–104

3. Font A, Domènech M, Benítez R, Rava M, Marqués M, Ramírez JL, Pineda S, Domínguez-Rodríguez S, Gago JL, Badal J, Carrato C, López H, Quer A, Castellano D, Malats N, Real FX (2020) Immunohistochemistry-based taxonomical classification of bladder cancer predicts response to neoadjuvant chemotherapy. Cancers (Basel) 12(7):1784

4. Olkhov-Mitsel E, Hodgson A, Liu SK, Vesprini D, Xu B, Downes MR (2021) Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression. J Clin Pathol :jclinpath-2021–207573

5. Taber A, Christensen E, Lamy P, Nordentoft I, Prip F, Lindskrog SV, Birkenkamp-Demtröder K, Okholm TLH, Knudsen M, Pedersen JS, Steiniche T, Agerbæk M, Jensen JB, Dyrskjøt L (2020) Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nat Commun 11(1):4858

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer—An Extensive Multiregional Immunohistochemical Analysis;European Urology Focus;2023-09

2. Molecular classification of muscle-invasive bladder cancer based on a simplified immunohistochemical panel using GATA3, CK5/6 and p16;Biomolecules and Biomedicine;2023-06-21

3. Scoring Systems for Immunohistochemistry in Urothelial Carcinoma;Urothelial Carcinoma;2023

4. Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression;Cancers;2022-12-28

5. Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification;Cancers;2022-10-07